Involvement of 5-hydroxytryptamine type 3 receptors in sevoflurane-induced hypnotic and analgesic effects in mice

Pharmacological Reports

Volumn 62, Issue 4, 2010, Pages 621-626

  Hang, Li Hua ^a,b   Shao, Dong Hua ^b   Wang, Hong ^b   Yang, Jian Ping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

Analgesia; Hypnosis; Receptors; Sevoflurane

Indexed keywords

2 (1H IMIDAZOL 4 YLMETHYL) 8H INDENO[1,2 D]THIAZOLE FUMARATE; ACETIC ACID; SEROTONIN 3 AGONIST; SEROTONIN 3 RECEPTOR; SEVOFLURANE; UNCLASSIFIED DRUG; YM 31636;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; EMULSION; FEMALE; HYPNOSIS; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; SLEEP TIME; WRITHING TEST;

EID: 77957996678     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70319-4     Document Type: Article

References (35)

1. Abraham MH, Acree WE Jr, Mintz C, Payne S: Effect of anesthetic structure on inhalation anesthesia: Implications for the mechanism. J Pharm Sci, 2008, 97, 2373-2384.
2. Alves HC, Valentim AM, Olsson IA, Antunes LM: Intraperitoneal anaesthesia with propofol, medetomidine and fentanyl in mice. Lab Anim, 2009, 43, 27-33.
3. Cascio M: Modulating inhibitory ligand-gated ion channels. AAPS J, 2006, 8, E353-361.
4. Chiari PC, Pagel PS, Tanaka K, Krolikowski JG, Ludwig LM, Trillo RA Jr, Puri N et al.: Intravenous emulsified halogenated anesthetics produce acute and delayed preconditioning against myocardial infarction in rabbits. Anesthesiology, 2004, 101, 1160-1166.
5. Filip M, Bader M: Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol Rep, 2009, 61, 761-777.
6. Hang L, Shao D, Yang Y, Sun W, Dai T, Zeng Y: α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors participate in the analgesic but not hypnotic effects of emulsified halogenated anaesthetics. Basic Clin Pharmacol Toxicol, 2008, 103, 31-35.
7. Hang LH, Shao DH, Yang YH, Dai TJ, Zeng YM: Spinal α -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors may mediate the analgesic effects of emulsified halogenated anaesthetics. Clin Exp Pharmacol Physiol, 2007, 34, 1121-1125.
8. Hemmings HC Jr, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL: Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci, 2005, 26, 503-510.
9. Hoyer D, Hannon JP, Martin GR: Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav, 2002, 71, 533-554.
10. Hylden JL, Wilcox GL: Intrathecal morphine in mice: A new technique. Eur J Pharmacol, 1980, 67, 313-316.
11. Ito H, Kiso T, Miyata K, Kamato T, Yuki H, Akuzawa S, Nagakura Y et al.: Pharmacological profile of YM-31636, a novel 5-HT3 receptor agonist, in vitro. Eur J Pharmacol, 2000, 409, 195-201.
12. Jansen M, Bali M, Akabas MH: Modular design of Cysloop ligand-gated ion channels: functional 5-HT3 and GABA ρ1 receptors lacking the large cytoplasmic M3M4 loop. J Gen Physiol, 2008, 131, 137-146.
13. Kayser V, Elfassi IE, Aubel B, Melfort M, Julius D, Gingrich JA, Hamon M, Bourgoin S: Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/-and 5-HTT-/-knock-out male mice. Pain, 2007, 130, 235-248.
14. Laursen SE, Belknap JK: Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods, 1986, 16, 355-357.
15. Mantz J, Dahmani S: Exploring the mechanisms of general anesthesia. Acta Anaesthesiol Belg, 2008, 59, 167-171.
16. Mukaida K, Shichino T, Koyanagi S, Himukashi S, Fukuda K: Activity of the serotonergic system during isoflurane anesthesia. Anesth Analg, 2007, 104, 836-839.
17. Nguyen HT, Li KY, daGraca RL, Delphin E, Xiong M, Ye JH: Behavior and cellular evidence for propofolinduced hypnosis involving brain glycine receptors. Anesthesiology, 2009, 110, 326-332.
18. Oyama T, Ueda M, Kuraishi Y, Akaike A, Satoh M: Dual effect of serotonin on formalin-induced nociception in the rat spinal cord. Neurosci Res,1996, 25, 129-135.
19. Perouansky M: Non-immobilizing inhalational anestheticlike compounds. Handb Exp Pharmacol, 2008, 209-223.
20. Peters JA, Hales TG, Lambert JJ: Molecular determinants of single-channel conductance and ion selectivity in the cys-loop family: Insights from the 5-HT3 receptor. Trends Pharmacol Sci, 2005, 26, 587-594.
21. Rampil IJ: Anesthetic potency is not altered after hypothermic spinal cord transection in rats. Anesthesiology, 1994, 80, 606-610.
22. Rampil IJ, Mason P, Singh H: Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology, 1993, 78, 707-712.
23. Solt K, Forman SA: Correlating the clinical actions and molecular mechanisms of general anesthetics. Curr Opin Anaesthesiol, 2007, 20, 300-306.
24. Sonner JM, Werner DF, Elsen FP, Xing Y, Liao M, Harris RA, Harrison NL et al.: Effect of isoflurane and other potent inhaled anesthetics on minimum alveolar concentration, learning, and the righting reflex in mice engineered to express alpha1 gamma-aminobutyric acid type a receptors unresponsive to isoflurane. Anesthesiology, 2007, 106, 107-113.
25. Stevens RJ, Rüsch D, Davies PA, Raines DE: Molecular properties important for inhaled anesthetic action on human 5-HT3A receptors. Anesth Analg, 2005, 100, 1696-1703.
26. Stevens R, Rüsch D, Solt K, Raines DE, Davies PA: Modulation of human 5-hydroxytryptamine type 3AB receptors by volatile anesthetics and n-alcohols. J Pharmacol Exp Ther, 2005, 314, 338-345.
27. Suzuki R, Morcuende S, Webber M, Hunt SP, Dickenson AH: Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat Neurosci, 2002, 5, 1319-1326.
28. Suzuki T, Koyama H, Sugimoto M, Uchida I, Mashimo T: The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine3 receptors expressed in Xenopus oocytes. Anesthesiology, 2002, 96, 699-704.
29. Urban B: Current assessment of targets and theories of anaesthesia. Br J Anaesth, 2002, 89, 167-183.
30. Urban BW: The site of anesthetic action. Handb Exp Pharmacol, 2008, 3-29.
31. Vilela FC, de Mesquita Padilha M, Dos Santos-E-Silva L, Alves-da-Silva G, Giusti-Paiva A: Evaluation of the antinociceptive activity of extracts of Sonchus oleraceus L. in mice. J Ethnopharmacol, 2009, 124, 306-310.
32. Westphalen RI, Hemmings HC Jr: Volatile anesthetic effects on glutamate versus GABA release from isolated rat cortical nerve terminals: Basal release. J Pharmacol Exp Ther, 2006, 316, 208-215.
33. + channel, TREK-1. Br J Pharmacol, 2007, 152, 939-945.
34. Yang XL, Ma HX, Yang ZB, Liu AJ, Luo NF, Zhang WS, Wang L et al.: Comparison of minimum alveolar concentration between intravenous isoflurane lipid emulsion and inhaled isoflurane in dogs. Anesthesiology, 2006, 104, 482-487.
35. Zhou JX, Luo NF, Liang XM, Liu J: The efficacy and safety of intravenous emulsified isoflurane in rats. Anesth Analg, 2006, 102, 129-134.